We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.57%
This Fund
S&P 500
This Quarter
Est. Return
+7.76%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
–
AUM
$27.7B
AUM Growth
+$1.67B
(+6.4%)
Cap. Flow
+$250M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
1,516
New
194
Increased
503
Reduced
567
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$579M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$371M |
| 3 |
Amazon
AMZN
|
+$367M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$235M |
| 5 |
ExxonMobil
XOM
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$442M |
| 2 |
Salesforce
CRM
|
+$407M |
| 3 |
T-Mobile US
TMUS
|
+$331M |
| 4 |
Home Depot
HD
|
+$283M |
| 5 |
PayPal
PYPL
|
+$247M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.21% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 12.48% |
| 4 | Communication Services | 9.55% |
| 5 | Financials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Spyre Therapeutics
SYRE
$9.29B
| $143K | ﹤0.01% |
12,738
| – | – |
|
|
TAST
1327
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $142K | ﹤0.01% |
104,653
-125,338
| -54% | -$195K |
|
1328
Newell Brands
NWL
$2.51B
| $134K | ﹤0.01% |
10,221
-1,024
| -9% | -$14K |
|
1329
Elanco Animal Health
ELAN
$11.1B
| $133K | ﹤0.01% |
10,853
-1,873
| -15% | -$23.3K |
|
1330
Lumen
LUMN
$6.85B
| $122K | ﹤0.01% |
23,317
-5,858
| -20% | -$36K |
|
|
SPNE
1331
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $118K | ﹤0.01% |
14,128
-102,567
| -88% | -$691K |
|
1332
Avita Medical
RCEL
$235M
| $108K | ﹤0.01% |
16,370
-17,123
| -51% | -$103K |
|
1333
Red Robin
RRGB
$150M
| $108K | ﹤0.01% |
19,300
-160,150
| -89% | -$1.19M |
|
1334
Kratos Defense & Security Solutions
KTOS
$11.7B
| $104K | ﹤0.01% |
10,079
-10,967
| -52% | -$109K |
|
|
FARM
1335
DELISTED
Farmer Brothers
FARM
| $82K | ﹤0.01% |
17,854
| – | – |
|
1336
Avalo Therapeutics
AVTX
$1.06B
| $79K | ﹤0.01% |
65
| – | – |
|
1337
Lennar Class B
LEN.B
$20.2B
| $50K | ﹤0.01% |
701
-42,450
| -98% | -$2.76M |
|
1338
Protara Therapeutics
TARA
$231M
| $46K | ﹤0.01% |
17,336
-41,053
| -70% | -$130K |
|
|
MAGN
1339
Magnera Corp
MAGN
$466M
| $36K | ﹤0.01% |
+991
| New | +$40.5K |
|
|
LCI
1340
DELISTED
Lannett Company, Inc.
LCI
| $6K | ﹤0.01% |
+3,110
| New | +$6.7K |
|
1341
Acadia Healthcare
ACHC
$2.96B
| – | – |
-13,556
| Closed | -$1.06M |
|
1342
ACI Worldwide
ACIW
$5.34B
| – | – |
-179,778
| Closed | -$3.76M |
|
1343
Addus HomeCare
ADUS
$2.23B
| – | – |
-4,433
| Closed | -$422K |
|
1344
Alamos Gold
AGI
$13.9B
| – | – |
-208,310
| Closed | -$1.54M |
|
1345
Adecoagro
AGRO
$1.39B
| – | – |
-28,762
| Closed | -$238K |
|
1346
Allegiant Air
ALGT
$2.41B
| – | – |
-4,700
| Closed | -$343K |
|
1347
Alaska Air
ALK
$5.27B
| – | – |
-304,606
| Closed | -$11.9M |
|
1348
Amplify Energy
AMPY
$172M
| – | – |
-56,628
| Closed | -$372K |
|
1349
Ameresco
AMRC
$1.34B
| – | – |
-4,171
| Closed | -$277K |
|
1350
American Superconductor
AMSC
$1.5B
| – | – |
-330,251
| Closed | -$1.45M |
|
Similar funds
Assenagon Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Assenagon Asset Management held 1,516 positions worth $27.7B, up 6.4% from $26.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Assenagon Asset Management's Q4 2022 filing shows 194 new, 503 increased, 567 reduced and 174 closed positions. Its largest new stake was Autoliv: 905,829 shares worth $69.4M. The largest sale was Pfizer, an estimated $442M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Assenagon Asset Management's largest Q4 2022 buy was Autoliv: 905,829 shares worth $69.4M.
- Assenagon Asset Management added most to Alphabet (Google) Class A in Q4 2022, an estimated $579M increase.
- Assenagon Asset Management's biggest Q4 2022 reduction was Pfizer, cutting an estimated $442M.
- Assenagon Asset Management fully exited PBF Energy in Q4 2022, selling an estimated $54.3M.
- Assenagon Asset Management's ten largest holdings make up 25% of its $27.7B portfolio in Q4 2022.
- Assenagon Asset Management opened 194 new positions and closed 174 in Q4 2022.
- Assenagon Asset Management's portfolio value rose 6.4% quarter-over-quarter to $27.7B.
Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.